1. Home
  2. ALT vs SMTI Comparison

ALT vs SMTI Comparison

Compare ALT & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SMTI
  • Stock Information
  • Founded
  • ALT 1997
  • SMTI 1982
  • Country
  • ALT United States
  • SMTI United States
  • Employees
  • ALT N/A
  • SMTI N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SMTI Medical/Dental Instruments
  • Sector
  • ALT Health Care
  • SMTI Health Care
  • Exchange
  • ALT Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • ALT 292.0M
  • SMTI 243.3M
  • IPO Year
  • ALT N/A
  • SMTI N/A
  • Fundamental
  • Price
  • ALT $3.67
  • SMTI $33.94
  • Analyst Decision
  • ALT Strong Buy
  • SMTI Strong Buy
  • Analyst Count
  • ALT 6
  • SMTI 2
  • Target Price
  • ALT $17.40
  • SMTI $50.00
  • AVG Volume (30 Days)
  • ALT 2.8M
  • SMTI 45.7K
  • Earning Date
  • ALT 08-12-2025
  • SMTI 08-13-2025
  • Dividend Yield
  • ALT N/A
  • SMTI N/A
  • EPS Growth
  • ALT N/A
  • SMTI N/A
  • EPS
  • ALT N/A
  • SMTI N/A
  • Revenue
  • ALT $20,000.00
  • SMTI $97,241,894.00
  • Revenue This Year
  • ALT N/A
  • SMTI $24.49
  • Revenue Next Year
  • ALT $761,880.20
  • SMTI $14.43
  • P/E Ratio
  • ALT N/A
  • SMTI N/A
  • Revenue Growth
  • ALT N/A
  • SMTI 34.29
  • 52 Week Low
  • ALT $2.90
  • SMTI $23.53
  • 52 Week High
  • ALT $11.16
  • SMTI $39.08
  • Technical
  • Relative Strength Index (RSI)
  • ALT 46.45
  • SMTI 67.79
  • Support Level
  • ALT $3.35
  • SMTI $29.33
  • Resistance Level
  • ALT $3.66
  • SMTI $34.50
  • Average True Range (ATR)
  • ALT 0.18
  • SMTI 1.70
  • MACD
  • ALT 0.05
  • SMTI 0.65
  • Stochastic Oscillator
  • ALT 58.57
  • SMTI 94.48

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: